Literature DB >> 27508882

Toll-like receptor 9 enhances bacterial clearance and limits lung consolidation in murine pneumonia caused by methicillin resistant Staphylococcus aureus.

Anne Jan van der Meer1, Achmed Achouiti1, Arie van der Ende2, Aicha A Soussan3, Sandrine Florquin4, Alex de Vos1, Sacha S Zeerleder5,3, Tom van der Poll1,6.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen in pneumonia, associated with severe lung damage. Tissue injury causes release of Damage Associated Molecular Patterns (DAMPs), which may perpetuate inflammation. DNA has been implicated as a DAMP that activates inflammation through Toll-like receptor (TLR)9. The aim of this study was to evaluate the role of TLR9 in MRSA pneumonia. Wild-type (Wt) and TLR9 knockout (tlr9-/-) mice were infected intranasally with MRSA USA300 (BK 11540) (5E7CFU) and euthanized at 6,24,48 or 72 hours for analyses. MRSA pneumonia was associated with profound release of cell-free host DNA in the airways, as reflected by increases in nucleosome and DNA levels in bronchoalveolar lavage fluid (BALF), accompanied by transient detection of pathogen DNA in MRSA-free BALF supernatants. In BALF, as compared to Wt -mice tlr9-/- mice showed reduced TNFα and IL-6 levels at 6 hours and reduced bacterial clearance at 6 and 24 hours post infection. Furthermore, tlr9-/- mice exhibited a greater influx of neutrophils in BALF and increased lung consolidation at 24 and 48 hours. This study demonstrates the release of host- and pathogen-derived TLR9 ligands (DNA) into the alveolar space after infection with MRSA via the airways and suggests that TLR9 has pro-inflammatory effects during MRSA pneumonia associated with enhanced bacterial clearance and limitation of lung consolidation.

Entities:  

Keywords:  DNA; Interleukin-6; Neutrophils; Nucleosomes; Tumor Necrosis Factor-alpha

Year:  2016        PMID: 27508882      PMCID: PMC5023514          DOI: 10.2119/molmed.2015.00242

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  47 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

2.  Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1.

Authors:  Marisa I Gómez; Aram Lee; Bharat Reddy; Amanda Muir; Grace Soong; Allyson Pitt; Ambrose Cheung; Alice Prince
Journal:  Nat Med       Date:  2004-07-11       Impact factor: 53.440

3.  TLR4 activity is required in the resolution of pulmonary inflammation and fibrosis after acute and chronic lung injury.

Authors:  Hong-Zhen Yang; Jia-Ping Wang; Su Mi; Han-Zhi Liu; Bing Cui; Hui-Min Yan; Jun Yan; Zhe Li; Hong Liu; Fang Hua; Wange Lu; Zhuo-Wei Hu
Journal:  Am J Pathol       Date:  2011-11-07       Impact factor: 4.307

Review 4.  How dying cells alert the immune system to danger.

Authors:  Hajime Kono; Kenneth L Rock
Journal:  Nat Rev Immunol       Date:  2008-03-14       Impact factor: 53.106

Review 5.  Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat.

Authors:  Hajo Grundmann; Marta Aires-de-Sousa; John Boyce; Edine Tiemersma
Journal:  Lancet       Date:  2006-09-02       Impact factor: 79.321

6.  Lipoproteins in Staphylococcus aureus mediate inflammation by TLR2 and iron-dependent growth in vivo.

Authors:  Mathias Schmaler; Naja J Jann; Fabrizia Ferracin; Lea Z Landolt; Lalitha Biswas; Friedrich Götz; Regine Landmann
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

Review 7.  The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer.

Authors:  Jan M Ehrchen; Cord Sunderkötter; Dirk Foell; Thomas Vogl; Johannes Roth
Journal:  J Leukoc Biol       Date:  2009-05-18       Impact factor: 4.962

8.  Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.

Authors:  Stephen E Girardin; Ivo G Boneca; Jérôme Viala; Mathias Chamaillard; Agnès Labigne; Gilles Thomas; Dana J Philpott; Philippe J Sansonetti
Journal:  J Biol Chem       Date:  2003-01-13       Impact factor: 5.157

9.  Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis.

Authors:  George Plitas; Bryan M Burt; Hoang M Nguyen; Zubin M Bamboat; Ronald P DeMatteo
Journal:  J Exp Med       Date:  2008-05-12       Impact factor: 14.307

10.  High cell-free DNA predicts fatal outcome among Staphylococcus aureus bacteraemia patients with intensive care unit treatment.

Authors:  Erik Forsblom; Janne Aittoniemi; Eeva Ruotsalainen; Visa Helmijoki; Reetta Huttunen; Juulia Jylhävä; Mikko Hurme; Asko Järvinen
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

View more
  4 in total

1.  CpG-DNA exerts antibacterial effects by protecting immune cells and producing bacteria-reactive antibodies.

Authors:  Te Ha Kim; Dongbum Kim; Avishekh Gautam; Heesu Lee; Min Hyung Kwak; Min Chul Park; Sangkyu Park; Guang Wu; Bok Luel Lee; Younghee Lee; Hyung-Joo Kwon
Journal:  Sci Rep       Date:  2018-11-02       Impact factor: 4.379

2.  The Azithromycin Pro-Drug CSY5669 Boosts Bacterial Killing While Attenuating Lung Inflammation Associated with Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus.

Authors:  Anno Saris; Wanhai Qin; Christine C A van Linge; Tom D Y Reijnders; Sandrine Florquin; Michael Burnet; Simon Strass; Alex F de Vos; Tom van der Poll
Journal:  Antimicrob Agents Chemother       Date:  2022-08-16       Impact factor: 5.938

Review 3.  Klebsiella pneumoniae infection biology: living to counteract host defences.

Authors:  José A Bengoechea; Joana Sa Pessoa
Journal:  FEMS Microbiol Rev       Date:  2019-03-01       Impact factor: 16.408

4.  Influenza-induced immune suppression to methicillin-resistant Staphylococcus aureus is mediated by TLR9.

Authors:  Giovanny J Martínez-Colón; Helen Warheit-Niemi; Stephen J Gurczynski; Quincy M Taylor; Carol A Wilke; Amy B Podsiad; Joel Crespo; Urvashi Bhan; Bethany B Moore
Journal:  PLoS Pathog       Date:  2019-01-25       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.